Key result
It remains unclear whether the well-documented increased patency rate of arterial grafts compared to saphenous vein grafts translates into clinical benefits in coronary artery bypass grafting.
Why the study?
It is unclear whether the well-documented increased patency rate of arterial grafts translates into clinical benefits in the majority of patients undergoing coronary artery bypass grafting.
Does the use of arterial grafts improve clinical outcomes compared to saphenous vein grafts in patients undergoing coronary artery bypass grafting?
Does the use of arterial grafts improve clinical outcomes compared to saphenous vein grafts in patients undergoing coronary artery bypass grafting?
Despite better patency rates of arterial grafts, definitive evidence of clinical benefit over saphenous vein grafts in CABG remains unclear, awaiting results from the ongoing ROMA trial.
Observational and randomized evidence shows that arterial grafts have better patency rates than saphenous vein grafts (SVGs) in coronary artery bypass grafting. Observational studies suggest that the use of multiple arterial grafts is associated with longer postoperative survival, but this must be interpreted in the context of treatment allocation bias and hidden confounders intrinsic to the study designs. Recently, a pooled analysis of 6 randomized trials comparing the radial artery with the SVG as the second conduit and the largest randomized trial comparing the use of single and bilateral internal thoracic arteries have provided apparently divergent results about a clinical benefit with the use of >1 arterial conduit. However, both analyses have methodological limitations that may have influenced their results. At present, it is unclear whether the well-documented increased patency rate of arterial grafts translates into clinical benefits in the majority of patients undergoing coronary artery bypass grafting. A large randomized trial testing the arterial grafts hypothesis (ROMA [Randomized Comparison of the Clinical Outcome of Single Versus Multiple Arterial Grafts]) is underway and will report the results in a few years.
No takes yet. Share an insight, caveat, or question.
Gaudino et al. (2019) conducted a review in Coronary artery bypass grafting. Arterial grafts vs. Saphenous vein grafts was evaluated. It remains unclear whether the well-documented increased patency rate of arterial grafts compared to saphenous vein grafts translates into clinical benefits in coronary artery bypass grafting.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: